about
Advanced precancerous lesions in the liverEtiology, natural history and treatment of hepatocellular carcinoma.Role of transjugular liver biopsy in the diagnostic and therapeutic management of patients with severe liver disease.Outcome of liver disease in a large cohort of histologically proven chronic hepatitis C: influence of HCV genotype.High prevalence of multinodular hepatocellular carcinoma in patients with cirrhosis attributable to multiple risk factors.Increased survival of cirrhotic patients with a hepatocellular carcinoma detected during surveillance.PNPLA3 I148M polymorphism, clinical presentation, and survival in patients with hepatocellular carcinomaA genomic and clinical prognostic index for hepatitis C-related early-stage cirrhosis that predicts clinical deteriorationPrognostic gene expression signature for patients with hepatitis C-related early-stage cirrhosisDeterminants of esophageal varices bleeding in patients with advanced hepatocellular carcinoma treated with sorafenib.Treatment of hepatocellular carcinoma: beyond international guidelines.Early diagnosis of liver cancer: an appraisal of international recommendations and future perspectives.Treatment of hepatocellular carcinoma: beyond international guidelines.Molecular Liver Cancer Prevention in Cirrhosis by Organ Transcriptome Analysis and Lysophosphatidic Acid Pathway Inhibition.A cell culture system for distinguishing hepatitis C viruses with and without liver cancer-related mutations in the viral core gene.[Hepatocellular carcinoma].Hepatitis B virus (HBV) DNA integration in patients with occult HBV infection and hepatocellular carcinoma.A hepatic stellate cell gene expression signature associated with outcomes in hepatitis C cirrhosis and hepatocellular carcinoma after curative resectionTransarterial chemoembolization with drug-eluting beads is effective for the maintenance of the Milan-in status in patients with a small hepatocellular carcinoma.Specificity of the hepatitis C virus antibody ELISA in patients with hepatocellular carcinoma.HCV genotypes in Northern Italy: a survey of 1368 histologically proven chronic hepatitis C patients.Association between heterozygosity for HFE gene mutations and hepatitis viruses in hepatocellular carcinoma.Hepatitis C virus genotype 1b, cirrhosis, and risk of hepatocellular carcinoma.Transarterial chemoembolization with epirubicin-eluting beads versus transarterial embolization before liver transplantation for hepatocellular carcinoma.Contrast enhanced CT-scan to diagnose intrahepatic cholangiocarcinoma in patients with cirrhosis.Increased expression of vascular endothelial growth factor in small hepatocellular carcinoma.Bacterial infection in patients with advanced cirrhosis: a multicentre prospective study.Beta-blockers in the secondary prevention of gastrointestinal haemorrhage in well-compensated cirrhotics. A multicentre randomised controlled study.Patterns of appearance and risk of misdiagnosis of intrahepatic cholangiocarcinoma in cirrhosis at contrast enhanced ultrasound.A 28-year study of the course of hepatitis Delta infection: a risk factor for cirrhosis and hepatocellular carcinoma.How I manage my patients with hepatocellular carcinoma.Contrast ultrasound LI-RADS LR-5 identifies hepatocellular carcinoma in cirrhosis in a multicenter restropective study of 1,006 nodules.Transarterial embolization with microspheres in the treatment of monofocal HCC.Persistence of hepatocellular carcinoma risk in hepatitis c patients with a response to ifn and cirrhosis regression.Prognostic ability of BCLC-B Subclassification in Patients with Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization.Clinical and economical impact of 2010 AASLD guidelines for the diagnosis of hepatocellular carcinoma.Diagnosis of hepatocellular carcinoma in cirrhosis by dynamic contrast imaging: the importance of tumor cell differentiation.Circulating miR-106b-3p, miR-101-3p and miR-1246 as diagnostic biomarkers of hepatocellular carcinoma.Surveillance for hepatocellular carcinoma: a standard of care, not a clinical optionCholangiocarcinoma in Cirrhosis: Value of Hepatocyte Specific Magnetic Resonance Imaging
P50
Q28293626-66F62A39-8336-4ABE-B12E-968D666AA161Q33357797-27EB8C04-3BE5-4E1B-A6C0-1B3889518DB9Q33381077-9290278F-30C1-41CD-A7EB-07EE045E804CQ34276310-5EFC72A7-55DF-43EE-8615-515FE9F9E072Q34503653-1726F996-3D95-4687-9C88-8DE1D55D5E7EQ34546781-9371FE77-BB8D-4D38-976F-C54A8926666FQ35025215-22DB5CB5-1DB1-49B3-A883-14DC7F7B6E25Q35107005-43458E68-8F74-4B0D-B1D2-3C64B376530FQ36788468-6D026C9A-F546-4101-B6AB-BF088DCE460CQ37045749-DAC40BC7-92D6-4AFB-A4EE-93C289FD9815Q38295870-D735C792-56EA-4A68-B5A3-1D4A802DEBA6Q38589516-C2AFF51E-E7BA-4B7F-943E-9AE4073FFE6EQ38685608-B0BD5771-7AAF-467D-A4A1-A35C522E8E9BQ38726399-6BC18576-7DDB-45D4-95AE-93080888E0DFQ38848401-BBAC7EAB-060E-4E05-A06B-E1703E62C01DQ40559850-FF0585F9-E7DB-4B54-AC11-3B28356D5645Q41486355-5966CAA0-E1A3-44F6-811B-47BC0CFB86D9Q41642597-BE4931FF-B1F7-4CD6-8019-9EEC9395DCC5Q41669686-C825E8FE-A609-445F-8DFF-99F2B1162DECQ42987981-69724502-41EF-485A-A106-1A68858087EDQ42991121-B002A19B-4299-48D8-A4D1-E6293FD332B9Q42992460-50061A30-2B7E-4EC2-A374-FA329CC25C26Q43047932-17B21EDA-6FCA-4951-94B8-85C0DFD52E15Q43185470-A8BA318D-68BF-40FA-AD3E-9DBC82191A01Q43474554-824B3307-6487-46DC-B008-6ADA6705BE7BQ43530331-ED8C4DE3-C79F-4204-AFA9-CA9130DC7389Q44105999-1459DD46-8EC5-44F5-9D18-89244067988DQ44118949-772704BF-279F-4695-912B-7431263D8842Q45809695-7B24B9EE-83CE-4C4B-989C-8285327050C6Q46126089-16E53C8F-4272-44DC-B35A-1A6009813342Q47595449-2BD5274D-DB04-4CDB-9534-B157A3908755Q47605018-B8C6B2CB-63C1-419D-A0B3-0A94EAD0F780Q47750627-A0883EF1-2261-4FF4-AA57-1BBCDE57EB2EQ49607585-542C9309-561B-4314-80C4-3FCA92251D55Q50133184-142531DC-6C13-4776-B65B-8AF0AFBB5BF7Q51119850-411414FE-C234-4621-A0C1-46CAA9BDBD29Q53272486-4C285353-609E-4E63-9407-F557FFE4BFFAQ55378766-944C7BCB-E41A-4653-A13A-52A74ABB4042Q56775897-CC3F7B6B-497F-4B8E-A058-6A07B51A2425Q56968191-4C5FCCCF-9A89-4D48-A4D2-100E2F11CA99
P50
description
Forscher
@de
chercheur
@fr
investigador
@es
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
研究者
@zh
name
Angelo Sangiovanni
@ast
Angelo Sangiovanni
@en
Angelo Sangiovanni
@es
Angelo Sangiovanni
@nl
type
label
Angelo Sangiovanni
@ast
Angelo Sangiovanni
@en
Angelo Sangiovanni
@es
Angelo Sangiovanni
@nl
prefLabel
Angelo Sangiovanni
@ast
Angelo Sangiovanni
@en
Angelo Sangiovanni
@es
Angelo Sangiovanni
@nl
P106
P1153
7003852097
P21
P31
P496
0000-0002-9996-9385